Invention Application
- Patent Title: QUINOLINYL AND BENZOTHIAZOLYL MODULATORS
-
Application No.: US12372699Application Date: 2009-02-17
-
Publication No.: US20090221635A1Publication Date: 2009-09-03
- Inventor: Lawrence R. McGee , Jonathan B. Houze , Steven M. Rubenstein , Atsushi Hagiwara , Noboru Furukawa , Hisashi Shinkai
- Applicant: Lawrence R. McGee , Jonathan B. Houze , Steven M. Rubenstein , Atsushi Hagiwara , Noboru Furukawa , Hisashi Shinkai
- Applicant Address: US CA Thousand Oaks JP Tokyo
- Assignee: Amgen Inc.,Japan Tobacco. Inc.
- Current Assignee: Amgen Inc.,Japan Tobacco. Inc.
- Current Assignee Address: US CA Thousand Oaks JP Tokyo
- Main IPC: A61K31/47
- IPC: A61K31/47 ; A61P29/00
Abstract:
Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PPARγ. In particular, the compounds of the invention modulate the function of PPARγ. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis.
Public/Granted literature
- US07960408B2 Quinolinyl and benzothiazolyl modulators Public/Granted day:2011-06-14
Information query
